Growth Metrics

Catalyst Pharmaceuticals (CPRX) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.32%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -10.19%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 24.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.92%
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn -19.77%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -19.77%
Dec 31, 2025 -23.41%
Sep 30, 2025 -21.96%
Jun 30, 2025 -6.36%
Mar 31, 2025 -5.28%
Dec 31, 2024 13.31%
Sep 30, 2024 16.36%
Jun 30, 2024 2.00%
Mar 31, 2024 1.79%
Dec 31, 2023 41.09%
Sep 30, 2023 34.47%
Jun 30, 2023 31.19%
Mar 31, 2023 38.92%
Dec 31, 2022 -11.68%
Sep 30, 2022 -7.26%
Jun 30, 2022 0.33%
Mar 31, 2022 -2.01%
Dec 31, 2021 637.69%
Sep 30, 2021 537.75%
Jun 30, 2021 445.63%
Mar 31, 2021 379.37%
Dec 31, 2020 -38.23%
Sep 30, 2020 5.69%
Jun 30, 2020 13.48%
Mar 31, 2020 40.34%
Dec 31, 2019 -14.24%
Sep 30, 2019 -29.84%
Jun 30, 2019 -21.11%
Mar 31, 2019 -23.48%
Dec 31, 2018 28.24%
Sep 30, 2018 -2.12%
Jun 30, 2018 -14.27%
Mar 31, 2018 -20.70%
Dec 31, 2017 -21.63%
Sep 30, 2017 -17.50%
Jun 30, 2017 -15.56%
Mar 31, 2017 29.66%
Dec 31, 2016 27.49%
Sep 30, 2016 26.01%
Jun 30, 2016 308.44%
Mar 31, 2016 150.71%
Dec 31, 2015 168.36%
Sep 30, 2015 177.27%
Jun 30, 2015 -3.21%
Mar 31, 2015 35.12%
Dec 31, 2014 75.68%
Sep 30, 2014 53.84%
Jun 30, 2014 25.66%
Mar 31, 2014 -8.83%
Dec 31, 2013 -24.31%
Sep 30, 2013 327.75%
Jun 30, 2013 283.90%
Mar 31, 2013 301.97%
Dec 31, 2012 340.50%
Sep 30, 2012 -40.75%
Jun 30, 2012 -47.32%
Dec 31, 2011 -73.26%